LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | PF431396 | 0.12 | uM | LJP5 | 72 | hr | 962 | 3745 | 10605 | 0.3532 | 0.2887 |
MCF 10A | PF477736 | 0.12 | uM | LJP5 | 72 | hr | 962 | 8621 | 10605 | 0.8129 | 0.7943 |
MCF 10A | PF562271 | 0.12 | uM | LJP6 | 72 | hr | 962 | 7356 | 10605 | 0.6936 | 0.6631 |
MCF 10A | PHA-665752 | 0.12 | uM | LJP5 | 72 | hr | 962 | 10179 | 10605 | 0.9598 | 0.9558 |
MCF 10A | PHA-793887 | 0.12 | uM | LJP6 | 72 | hr | 962 | 1859 | 10605 | 0.1753 | 0.0930 |
MCF 10A | PI103 | 0.12 | uM | LJP6 | 72 | hr | 962 | 5674 | 10605 | 0.5350 | 0.4886 |
MCF 10A | PLX-4720 | 0.12 | uM | LJP5 | 72 | hr | 962 | 9619 | 10605 | 0.9070 | 0.8977 |
MCF 10A | QL-X-138 | 0.12 | uM | LJP6 | 72 | hr | 962 | 10435 | 10605 | 0.9840 | 0.9824 |
MCF 10A | QL-XII-47 | 0.12 | uM | LJP6 | 72 | hr | 962 | 9610 | 10605 | 0.9062 | 0.8968 |
MCF 10A | Radicicol | 0.12 | uM | LJP5 | 72 | hr | 962 | 6589 | 10605 | 0.6214 | 0.5836 |
MCF 10A | Radicicol | 0.12 | uM | LJP6 | 72 | hr | 962 | 6550 | 10605 | 0.6177 | 0.5795 |
MCF 10A | Seliciclib | 0.12 | uM | LJP5 | 72 | hr | 962 | 10036 | 10605 | 0.9464 | 0.9411 |
MCF 10A | Ruxolitinib | 0.12 | uM | LJP5 | 72 | hr | 962 | 10299 | 10605 | 0.9712 | 0.9683 |
MCF 10A | XL147 | 0.12 | uM | LJP5 | 72 | hr | 962 | 10032 | 10605 | 0.9460 | 0.9406 |
MCF 10A | Saracatinib | 0.12 | uM | LJP6 | 72 | hr | 962 | 10264 | 10605 | 0.9678 | 0.9646 |
MCF 10A | Selumetinib | 0.12 | uM | LJP6 | 72 | hr | 962 | 3938 | 10605 | 0.3713 | 0.3086 |
MCF 10A | Sirolimus | 0.12 | uM | LJP6 | 72 | hr | 962 | 9527 | 10605 | 0.8984 | 0.8883 |
MCF 10A | Sorafenib | 0.12 | uM | LJP6 | 72 | hr | 962 | 9665 | 10605 | 0.9114 | 0.9025 |
MCF 10A | SU11274 | 0.12 | uM | LJP5 | 72 | hr | 962 | 9686 | 10605 | 0.9133 | 0.9047 |
MCF 10A | Fedratinib | 0.12 | uM | LJP5 | 72 | hr | 962 | 9510 | 10605 | 0.8968 | 0.8865 |
MCF 10A | TGX221 | 0.12 | uM | LJP5 | 72 | hr | 962 | 10564 | 10605 | 0.9961 | 0.9957 |
MCF 10A | Torin1 | 0.12 | uM | LJP6 | 72 | hr | 962 | 2496 | 10605 | 0.2354 | 0.1591 |
MCF 10A | Torin2 | 0.12 | uM | LJP5 | 72 | hr | 962 | 1535 | 10605 | 0.1447 | 0.0594 |
MCF 10A | Tozasertib | 0.12 | uM | LJP5 | 72 | hr | 962 | 1486 | 10605 | 0.1402 | 0.0544 |
MCF 10A | Trametinib | 0.12 | uM | LJP5 | 72 | hr | 962 | 1803 | 10605 | 0.1700 | 0.0872 |